Editorial: Repeated stool toxin testing for diagnosing difficile colitis is still valid

Southern Medical Journal

Volumn 102, Issue 10, 2009, Pages 993-994

  Arabi, Ziad ^a   Boxwalla, Asgar ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COLON RESECTION; EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; HUMAN; INFLUENZA; MORTALITY; NONHUMAN; SENSITIVITY ANALYSIS; CHEMISTRY; CROSS INFECTION; FECES; INCIDENCE; ISOLATION AND PURIFICATION; MICROBIOLOGY; NOTE; PSEUDOMEMBRANOUS COLITIS;

ENTEROTOXIN;

CLOSTRIDIUM DIFFICILE; CROSS INFECTION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; ENTEROTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; HUMANS; INCIDENCE;

EID: 70349823645     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e3181b4b0a6     Document Type: Editorial

References (14)

1. Gade RL, Turett G. The utility of repeated stool toxin testing for diagnosing Clostridium difficile colitis. South Med J 2009;102:1007-1009.
2. Bartlett JG, Gerding DN. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis 2008;46:S12-S18.
3. Kyne L, Hamel MB, Polavaram R, et al. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002;34:346-353.
4. Centers for Disease Control and Prevention (CDC). Surveillance for community- associated Clostridium Difficile-Connecticut, 2006. MMWR Morb Mortal Wkly Rep 2008;57:340-343.
5. Centers for Disease Control and Prevention (CDC). Update: influenza activity-United States, September 28, 2008-April 4, 2009, and composition of the 2009-10 influenza vaccine. MMWR Morb Mortal Wkly Rep 2009;58:369-374.
6. Muto CA, Pokrywka M, Shutt K, et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 2005;26:273-280.
7. Cober ED, Malani PN. Clostridium difficile infection in the "oldest" old: clinical outcomes in patients aged 80 and older. J Am Geriatr Soc 2009;57:659-662.
8. Zilberberg MD, Shorr AF, Kollef MH. Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis 2008;14:929-931.
9. Debast SB, van Kregten E, Oskam KM, et al. Effect on diagnostic yield of repeated stool testing during outbreaks of Clostridium difficile-associated disease. Clin Microbiol Infect 2008;14:622-624.
10. Nemat H, Khan R, Ashraf MS, et al. Diagnostic value of repeated enzyme immunoassays in Clostridium difficile infection. Am J Gastroenterol. 2009;104:2035-2041.
11. Cardona DM, Rand KH. Evaluation of repeat Clostridium difficile enzyme immunoassay testing. J Clin Microbiol 2008;46:3686-3689.
12. Fekety R, Shah AB. Diagnosis and treatment of Clostridium difficile colitis. JAMA 1993;269:71-75.
13. Kirkpatrick ID, Greenberg HM. Evaluating the CT diagnosis of Clostridium difficile colitis: should CT guide therapy? AJR Am J Roentgenol 2001;176:635-639.
14. O'Brien JA, Lahue BJ, Caro JJ, et al. The emerging infectious challenge of Clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol 2007;28:1219-1227.